METABOLIC CONTROL OF FEEDING BEHAVIOR
进食行为的代谢控制
基本信息
- 批准号:6610679
- 负责人:
- 金额:$ 30.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-08-01 至 2006-03-31
- 项目状态:已结题
- 来源:
- 关键词:adenosine triphosphate antimetabolites behavior prediction bioenergetics calcium flux carbohydrate analog laboratory rat liver cells liver metabolism mannitol nuclear magnetic resonance spectroscopy nutrient intake activity nutrition related tag obesity ouabain overeating psychobiology sodium potassium exchanging ATPase
项目摘要
DESCRIPTION (provided by applicant): Postabsorptive fuel metabolism is an important factor in the control of food intake. Sensors in brain and liver that are sensitive to various metabolic parameters have been implicated in this control. In liver, considerable evidence indicates that changes in energy metabolism produce a stimulus or stimuli that are transduced into a neural signal that carries this metabolic information to the central nervous system for use in controlling food intake. In particular, changes in hepatic ATP content, or some closely related change in liver energy status, generate signals that initiate or terminate feeding behavior under various conditions, such as fasting-refeeding, type I diabetes, and treatment with metabolic inhibitors. Recent studies in this laboratory have revealed that three different animal models of obesity (genetic, dietary and neurological) show reduced hepatic energy status, suggesting that changes in liver energy status are also involved in overeating and the development of obesity. The overall goal of this project is to assess whether and how altered hepatic energy metabolism is a contributing cause of hyperphagia (overeating) that leads to obesity. Some rats overeat and become obese when fed a diet high in fat content (obesity-prone), whereas others of the same strain do not (obesity-resistant). The proposed research will use this diet-induced animal model of obesity because it appears most comparable to the obesity commonly seen in humans. We hypothesize that, during the development of obesity, hyperphagia may be driven at least in part by decreased liver energy status, which is secondary to the redirection of fuels into storage and away from oxidative pathways. Overeating could result from a faster decline in hepatic energy status between meals or a slower recovery in hepatic energy status during and after a meal. The project has three specific aims: (1) Determine whether overeating in obesity prone rats is due to an enhanced susceptibility to reductions in liver energy status. (2) Determine whether overeating in obesity prone rats is due to a slow restoration of liver energy status. (3) Determine whether calcium signaling during metabolic stimulus transduction differs in hepatocytes from lean and obese rats.
描述(由申请人提供):吸收后燃料代谢是控制食物摄入的重要因素。大脑和肝脏中对各种代谢参数敏感的传感器与这种控制有关。在肝脏中,相当多的证据表明,能量代谢的变化产生一种或多种刺激,这些刺激被转换成神经信号,该神经信号将这种代谢信息携带到中枢神经系统,用于控制食物摄入。特别是,肝脏ATP含量的变化,或肝脏能量状态的一些密切相关的变化,产生在各种条件下启动或终止进食行为的信号,如禁食-再进食,I型糖尿病和代谢抑制剂治疗。该实验室最近的研究表明,三种不同的肥胖动物模型(遗传,饮食和神经)显示肝脏能量状态降低,这表明肝脏能量状态的变化也参与了暴饮暴食和肥胖的发展。该项目的总体目标是评估肝脏能量代谢的改变是否以及如何成为导致肥胖的暴食(暴饮暴食)的原因。当喂食高脂肪含量的饮食时,一些大鼠会吃得过多并变得肥胖(肥胖倾向),而其他相同品系的大鼠则不会(肥胖抵抗)。这项拟议中的研究将使用这种饮食诱导的肥胖动物模型,因为它似乎与人类常见的肥胖最具可比性。我们推测,在肥胖症的发展过程中,暴食症可能至少部分是由肝脏能量状态下降驱动的,这是继发于燃料重定向到储存和远离氧化途径。暴饮暴食可能是由于两餐之间肝脏能量状态下降较快或餐中和餐后肝脏能量状态恢复较慢所致。该项目有三个具体目标:(1)确定肥胖倾向大鼠的暴饮暴食是否是由于对肝脏能量状态降低的敏感性增强。(2)确定肥胖倾向大鼠的暴饮暴食是否是由于肝脏能量状态的缓慢恢复。(3)确定是否钙信号在代谢刺激转导不同的肝细胞从瘦和肥胖大鼠。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK FRIEDMAN其他文献
MARK FRIEDMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK FRIEDMAN', 18)}}的其他基金
相似海外基金
Antimetabolites Effective against Resistant Gram-positive Bacteria
抗代谢药可有效对抗耐药革兰氏阳性细菌
- 批准号:
8705774 - 财政年份:2014
- 资助金额:
$ 30.49万 - 项目类别:
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
一线抗代谢药物作为类固醇节约治疗 (FAST) 葡萄膜炎试验
- 批准号:
8549253 - 财政年份:2012
- 资助金额:
$ 30.49万 - 项目类别:
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
一线抗代谢药物作为类固醇节约治疗 (FAST) 葡萄膜炎试验
- 批准号:
8724947 - 财政年份:2012
- 资助金额:
$ 30.49万 - 项目类别:
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
一线抗代谢药物作为类固醇节约治疗 (FAST) 葡萄膜炎试验
- 批准号:
8266928 - 财政年份:2012
- 资助金额:
$ 30.49万 - 项目类别:














{{item.name}}会员




